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echocardiogram (TEE) was used to monitor patients cardiac status intraoperatively. Patient remained 
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Introduction
A case of a patient with severe dilated cardiomyopathy, 
undergoing small bowel resection. Anesthesia was managed 
with a combination of general/epidural anesthesia, in addition 
to IABP and TEE.
Case Report
A 37 year old white male presented to our surgical 
department for small bowel resection. Patient’s history was 
significant for rhabdomyosarcoma, diagnosed at the age of 
five. The rhabdomyosarcoma was treated, but recurred four 
years later. Patient’s treatment regimen included Adriamycin. 
On this presentation, patient’s medical history was significant 
for malignancy in the ileostomy that was a result of radiation 
enteritis. In addition, as a result of the treatment regimen, patient 
has developed severe non-ischemic dilated cardiomyopathy. 
Preoperative transthoracic echocardiogram was significant for 
severely dilated left ventricular (LV) cavity, LV ejection fraction 
of <10% and severe mitral regurgitation (MR).
On the day of surgery, a left radial arterial line was placed for 
close and accurate monitoring of hemodynamics. Unsuccessful 
attempts were made to cannulate both the internal jugular and 
the left subclavian veins. All three sites had been cannulated 
multiple times over the years. Patient had an indwelling catheter 
in the right subclavian. An epidural catheter was placed, both 
for intraoperative use and post operative pain control. General 
anesthesia was induced, intravenously, through an 18 gauge 
angiocath in the right upper extremity. After a smooth induction 
of anesthesia, the trachea was intubated and the position of the 
endotracheal tube confirmed. 
After emptying the stomach, the TEE probe was placed 
without difficulty. IABP was placed via the right femoral artery. 
Position of the IABP was confirmed with the TEE. Operation of 
the IABP was confirmed. A left femoral venous cordis was placed 
and central access was established. Preoperative TEE found an 
LV ejection fraction of approximately 5%, severely dilated LV 
(Figure 1a & Figure 1b), moderately dilated right ventricle, and 
moderate to severe right ventricular hypokinesis. Patient had a 
4+ MR, with significant reversal of the systolic component of the 
right superior pulmonary venous profile (Figures 1c & Figure 
1d).
Figure 1a & 1b: Transgarstric Short Axis view of the left ventricle 
showing severely dilated left ventricle.
During the surgery, anesthesia was maintained with 
narcotics, inhalational agent and the epidural. Patient remained 
hemodynamically stable during the procedure. No significant 
changes were noted on the TEE during the surgery. IABP 
functioned adequately, providing mechanical support.
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the procedure well.
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Figure 1c: Color Doppler image of the Mitral valve showing severe 
Mitral regurgitation (MR).
Figure 1d: Pulsed wave Doppler of the right superior pulmonary 
vein demonstrating reversal of the systolic component of the 
pulmonary venous profile. Consistent with the severe MR.
Discussion
Although our patient did not undergo an endocardial biopsy 
to confirm the etiology of his cardiomyopathy, Adriamycin 
cannot be ruled out as an etiological factor. Adriamycin is a 
chemotherapeutic agent, which belongs to the Anthracycline 
group of drugs. Anthracyclines are one of the most potent anti-
cancer drugs developed to date [1]. Adriamycin is considered 
a first line treatment of several cancers [2]. Adriamycin is an 
antibiotic obtained from cultivating Streptomyces peucetius var. 
caesius [3]. 
Cardiac toxicity of Adriamycin is well known. It is the cause of 
significant mortality and morbidity. Manifestation of Adriamycin 
cardiotoxicity can range from arrhythmias to nonspecific ECG 
changes to a reduction in LV ejection fraction [1]. Endomyocardial 
biopsy remains the definitive test for diagnosing anthracycline-
induced toxicity [4]. 
Risk factors for developing irreversible anthracycline-induced 
cardiotoxicity include high dose infusions, high cumulative 
doses, extremes of age (like our patient) and history of cardiac 
disease. History of previous mediastinal radiation therapy and 
the concurrent use of chemotherapeutic agents like paclitaxel 
or trastuzumab can contribute to anthracycline cardiotoxicity 
[5-8]. Incidence of cardiotoxicity ranges from 0.4 to 41% [1]. 
In the acute form, cardiomyopathy manifests as myocarditis-
pericarditis, usually within 24 hours of the infusion, with good 
long term prognosis. In it’s subacute form, it may manifest as 
late as 30 months after adriamycin therapy, with 60% mortality. 
Late form cardiomyopathy may not be seen until four to 20 
years later. This form is associated with echocardiographic and 
pathologic changes, in addition to heart failure [9].
Severity of cardiac dysfunction in our patient warranted 
aggressive anesthetic management. Although there are reports 
of using TEE in patients with severely dilated cardiomyopathy, 
[10,11] it was of paramount importance for our case, since we 
were unable to place a pulmonary artery catheter preoperatively 
for adequate hemodynamic monitoring. As it was critical not to 
overload this patient with fluids, TEE helped with monitoring 
the volume status. In our literature search, we did not come 
across any other case of severely dilated cardiomyopathy in 
which IABP was utilized to provide mechanical cardiac support. 
In our case, the afterload reduction, provided by the IABP, played 
a big role in the hemodynamic stability of this patient during the 
surgery. Placement of the epidural catheter, made it possible for 
us to limit our use of general anesthetics and avoid unnecessary 
depression of myocardial function.
Conclusion
At the conclusion of the surgery, patient was adequately 
reversed and extubated on the operating table. Patient was 
awake, alert, breathing spontaneously and pain free. Since 
the patient still had an IABP in place, he was transported to 
the cardiac intensive care unit for further postoperative care. 
Patient’s postoperative course remained uneventful.
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